These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 10207218

  • 1. In vivo gluten ingestion in coeliac disease.
    Ciclitira PJ, Ellis HJ.
    Dig Dis; 1998; 16(6):337-40. PubMed ID: 10207218
    [Abstract] [Full Text] [Related]

  • 2. The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease.
    Dewar DH, Amato M, Ellis HJ, Pollock EL, Gonzalez-Cinca N, Wieser H, Ciclitira PJ.
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):483-91. PubMed ID: 16607142
    [Abstract] [Full Text] [Related]

  • 3. Coeliac disease--a meeting point for genetics, immunology, and protein chemistry.
    Mowat AM.
    Lancet; 2003 Apr 12; 361(9365):1290-2. PubMed ID: 12699968
    [Abstract] [Full Text] [Related]

  • 4. In vivo gluten challenge in celiac disease.
    Ellis HJ, Ciclitira PJ.
    Can J Gastroenterol; 2001 Apr 12; 15(4):243-7. PubMed ID: 11331926
    [Abstract] [Full Text] [Related]

  • 5. Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
    Mamone G, Camarca A, Fierro O, Sidney J, Mazzarella G, Addeo F, Auricchio S, Troncone R, Sette A, Gianfrani C.
    J Agric Food Chem; 2013 Jan 23; 61(3):747-54. PubMed ID: 23244345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Wheat peptide challenge in coeliac disease.
    Sturgess R, Day P, Ellis HJ, Lundin KE, Gjertsen HA, Kontakou M, Ciclitira PJ.
    Lancet; 1994 Mar 26; 343(8900):758-61. PubMed ID: 7907731
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L, Troncone R, Mayer M, Coletta S, Picarelli A, De Vincenzi M, Pavone V, Auricchio S.
    Scand J Gastroenterol; 1996 Mar 26; 31(3):247-53. PubMed ID: 8833354
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Natural variants of α-gliadin peptides within wheat proteins with reduced toxicity in coeliac disease.
    Japelj N, Suligoj T, Zhang W, Côrte-Real B, Messing J, Ciclitira PJ.
    Br J Nutr; 2020 Jun 28; 123(12):1382-1389. PubMed ID: 32100654
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of gluten on HLA-DR in the small intestinal epithelium of patients with coeliac disease.
    Ciclitira PJ, Nelufer JM, Ellis HJ, Evans DJ.
    Clin Exp Immunol; 1986 Jan 28; 63(1):101-4. PubMed ID: 3514010
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
    Ciacci C, Maiuri L, Russo I, Tortora R, Bucci C, Cappello C, Santonicola A, Luciani A, Passananti V, Iovino P.
    Clin Exp Pharmacol Physiol; 2009 Dec 28; 36(12):1170-6. PubMed ID: 19473192
    [Abstract] [Full Text] [Related]

  • 14. Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.
    Stenman SM, Lindfors K, Venäläinen JI, Hautala A, Männistö PT, Garcia-Horsman JA, Kaukovirta-Norja A, Auriola S, Mauriala T, Mäki M, Kaukinen K.
    Clin Exp Immunol; 2010 Aug 28; 161(2):242-9. PubMed ID: 20560983
    [Abstract] [Full Text] [Related]

  • 15. Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease.
    Howdle PD.
    Eur J Gastroenterol Hepatol; 2006 Jul 28; 18(7):703-6. PubMed ID: 16772825
    [Abstract] [Full Text] [Related]

  • 16. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study.
    Catassi C, Rossini M, Rätsch IM, Bearzi I, Santinelli A, Castagnani R, Pisani E, Coppa GV, Giorgi PL.
    Gut; 1993 Nov 28; 34(11):1515-9. PubMed ID: 8244135
    [Abstract] [Full Text] [Related]

  • 17. Antigen-Specific Gut Inflammation and Systemic Immune Responses Induced by Prolonging Wheat Gluten Sensitization in BALB/c Murine Model.
    Vijaykrishnaraj M, Mohan Kumar BV, Muthukumar SP, Kurrey NK, Prabhasankar P.
    J Proteome Res; 2017 Oct 06; 16(10):3514-3528. PubMed ID: 28809572
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.
    Anderson RP, Goel G, Hardy MY, Russell AK, Wang S, Szymczak E, Zhang R, Goldstein KE, Neff K, Truitt KE, Williams LJ, Dzuris JL, Tye-Din JA.
    Clin Exp Immunol; 2021 Jun 06; 204(3):321-334. PubMed ID: 33469922
    [Abstract] [Full Text] [Related]

  • 20. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.
    Mazzarella G, Maglio M, Paparo F, Nardone G, Stefanile R, Greco L, van de Wal Y, Kooy Y, Koning F, Auricchio S, Troncone R.
    Gut; 2003 Jan 06; 52(1):57-62. PubMed ID: 12477760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.